Next Quarterly Earnings
Friday, October 9, 2026
Expected
Nurix Therapeutics
Nurix Therapeutics is a US-based biotech company specializing in innovative targeted protein modulation therapies. Utilizing its proprietary DEL platform, Nurix researches E3 ligase inhibitors and protein degraders to treat severe cancers and immune disorders through precise therapeutic intervention.
Recap: the latest results
Nurix Therapeutics (NRIX) reported its Q3 2026 financial results after market close on July 9, 2026. The company reported an EPS of -0.81 USD, missing the analyst estimate of -0.72 USD by 12.1%. Revenue for the quarter was 9 million USD. Following the release, the stock price fell by 6.60%.
Generated automatically from our data — as of 07/14/2026 Read the article →
Frequently asked questions
When did Nurix Therapeutics last report quarterly earnings?
Nurix Therapeutics last reported quarterly earnings on 7/9/2026 (Q2 2026). Earnings per share (EPS) came in at -0.81 USD.
How does Nurix Therapeutics stock react to earnings?
Across its last 4 earnings reports, Nurix Therapeutics stock moved by ±3.3% on average the following day. The largest reaction was -6.6% on 07/09/2026; 1 of 4 reactions were positive.
How often has Nurix Therapeutics beaten expectations?
Nurix Therapeutics has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
How do I add the Nurix Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±3.3%
Avg. next-day move
-6.6%
Largest move (07/09/2026)
25%
Share of positive reactions
±5.4%
Avg. move after 7 days
Basis: price reactions to the last 4 report dates (close to close).
Estimates vs. results
1/4
Quarters above estimates
25%
Beat rate
-2.5%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Nurix Therapeutics
Country
🇺🇸
More Financial Information